Holgate S - Search Results

1

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.

Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. Holgate S, et al. J Allergy Clin Immunol. 2005 Mar;115(3):459-65. doi: 10.1016/j.jaci.2004.11.053. J Allergy Clin Immunol. 2005. PMID: 15753888 Review.

2

Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.

Holgate S, Bousquet J, Wenzel S, Fox H, Liu J, Castellsague J. Holgate S, et al. Curr Med Res Opin. 2001;17(4):233-40. Curr Med Res Opin. 2001. PMID: 11922396

3

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD; Omalizumab 011 International Study Group. Holgate ST, et al. Clin Exp Allergy. 2004 Apr;34(4):632-8. doi: 10.1111/j.1365-2222.2004.1916.x. Clin Exp Allergy. 2004. PMID: 15080818 Clinical Trial.

4

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J. Holgate ST, et al. Clin Exp Allergy. 2005 Apr;35(4):408-16. doi: 10.1111/j.1365-2222.2005.02191.x. Clin Exp Allergy. 2005. PMID: 15836747 Review.

5

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P. Holgate S, et al. Respir Med. 2009 Aug;103(8):1098-113. doi: 10.1016/j.rmed.2009.03.008. Epub 2009 Apr 10. Respir Med. 2009. PMID: 19362459 Free article. Review.

6

Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma.

Bousquet J, Wenzel S, Holgate S, Lumry W, Freeman P, Fox H. Bousquet J, et al. Among authors: holgate s. Chest. 2004 Apr;125(4):1378-86. doi: 10.1378/chest.125.4.1378. Chest. 2004. PMID: 15078749 Clinical Trial.

7

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.

Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD. Bousquet J, et al. Among authors: holgate s. Allergy. 2005 Mar;60(3):302-8. doi: 10.1111/j.1398-9995.2004.00770.x. Allergy. 2005. PMID: 15679714

8

Safety and tolerability of omalizumab.

Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jimenez P. Corren J, et al. Among authors: holgate s. Clin Exp Allergy. 2009 Jun;39(6):788-97. doi: 10.1111/j.1365-2222.2009.03214.x. Epub 2009 Mar 17. Clin Exp Allergy. 2009. PMID: 19302249 Review.

9

Effects of omalizumab on markers of inflammation in patients with allergic asthma.

Holgate S, Smith N, Massanari M, Jimenez P. Holgate S, et al. Allergy. 2009 Dec;64(12):1728-36. doi: 10.1111/j.1398-9995.2009.02201.x. Epub 2009 Oct 15. Allergy. 2009. PMID: 19839977 Review.

10

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Brozek JL, et al. J Allergy Clin Immunol. 2010 Sep;126(3):466-76. doi: 10.1016/j.jaci.2010.06.047. J Allergy Clin Immunol. 2010. PMID: 20816182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,084 results

Search Page